Protecting the Consumer at the Heart of DTC Precision Medicine
Bill Of Health
OCTOBER 27, 2023
The HIPAA Problem The privatization of next-generation medical technologies, especially in regenerative and precision medicine, further muddies the data-protection waters. The innovation-security tradeoff is a familiar trope in biotechnology, but the main character of the direct-to-consumer tissue-based service story is less so.
62 
Let's personalize your content